Skip to main content
Premium Trial:

Request an Annual Quote

Biotage to Buy Argonaut s Flash Chromatography Business for $21.1M Next Month

NEW YORK, April 8 (GenomeWeb News) - Biotage is close to closing a deal to purchase stock and certain assets of Argonaut Technologies' flash chromatography business for $21.2 million in cash.

 

The closing of the deal is expected to happen "directly after" a shareholder's meeting in the second half of May, if Biotage shareholders vote in favor of the acquisition, Biotage CEO Jeff Bork said today.

 

In February, Biotage entered into an agreement to purchase Argonauts' assets for $19.9 million in cash. Under the amended agreement, Argonaut is selling additional assets, including specified liabilities, warranty service and maintenance, and accounts payable of up to $350,000 associated with Argonauts' remaining Process Development Products and Services business.

 

Following the close of the deal, Argonaut intends to distribute to stockholders a significant portion of the net proceeds.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.